Polyunsaturated fatty acids family n-3 - prooxidant or antioxidant factor in diabetes mellitus? - a review

• Autorzy: Grygiel-Gorniak B. , McEnemy J. , Przyslawski J.
• Języki publikacji: EN

Abstrakty

EN

Oxidative stress is considered as a likely causative factor in the development of insulin resistance leading to diabetes mellitus. Meals rich in lipids disturb the redox balance in humans. Some nutrients such as n-3 long-chain polyunsaturated fatty acids may enhance the oxidative processes, however many studies underline their possible beneficial effect in the prevention and treatment of diabetes mellitus. N-3 polyunsaturated fatty acids are obtained not only from naturally occurring foods but also from pharmaceutical n-3 supplements. Possible roles played by essential fatty acids, in the oxidative processes in diabetes mellitus, are discussed in light of recent evidence and available methods.

• Wydawca: -
• Czasopismo: Polish Journal of Food and Nutrition Sciences
• Rocznik: 2010
• Tom: 60
• Numer: 1
• Opis fizyczny: p.7-12,ref.

Twórcy

autor

Grygiel-Gorniak B.

• Department of Bromatology and Human Nutrition, University of Medical Sciences, 42 Marcelinska Str., 60-354 Poznan, Poland

autor

McEnemy J.

autor

Przyslawski J.

Bibliografia

• 1. Adeghate E., Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review. Mol. Cell Biochem., 2004, 261, 187–191.
• 2. Bae J.H., Bassenge E., Kim K.B., Kim Y.N., Kim K.S., Lee H.J., Moon K.C., Lee M.S., Park K.Y., Schwemmer M., Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis, 2002, 155, 517–523.
• 3. Bailey D.M., Davies B., Young I.S., Intermittent hypoxic training: implications for lipid peroxidation induced by acute normoxic exercise in active men. Clin. Sci. (Lond)., 2001, 101, 465–475.
• 4. Bauer M., Hamm A., Pankratz M.J., Linking nutrition to genomics. Biol. Chem., 2004, 385, 593–596.
• 5. Bloch-Damti A., Bashan N., Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox. Signal., 2005, 7, 1553–1567.
• 6. Boden G., Effects of free fatty acids on glucose metabolism: significance for insulin resistance and Type 2 Diabetes. Exp. Clin. Endocrinol. Diab., 2003, 111, 121–124.
• 7. Ceriello A., Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes, 2005, 54, 1–7.
• 8. Christensen J.H., Skou H A., Madsen T., Tørring I., Schmidt E.B., Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J. Int. Med., 2001, 249, 545–552.
• 9. Das U.N., Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot. Essent. Fatty Acids, 2000, 63, 351–362.
• 10. DeFilippis A.P., Sperling L.S., Understanding omega-3’s. Am. Heart J., 2006, 151, 564–570.
• 11. Dierckx N., Horvath G., van Gils C., Vertommen J., van de Vliet J., De Leeuwi I., Manuel-Y-Keenoy B., Oxidative stress status in patients with diabetes mellitus: relationship to diet. Eur. J. Clin. Nutr., 2003, 57, 999–1008.
• 12. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M., Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes, 2003, 52, 1–8.
• 13. Frantz S., Calvillo L., Tillmanns J., Elbing I., Dienesch C., Bischoff H., Ertl G., Bauersachs J., Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the alpha-glucosidase inhibitor acarbose. FASEB J., 2005, 19, 591–593.
• 14. Green K., Brand M.D., Murphy M.P., Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes., Diabetes, 2004, 53suppl., S110–S118.
• 15. Griendling K.K., FitzGerald G.A., Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation, 2003, 108, 2034–2040.
• 16. Haag M., Dippenaar N., Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection. Med. Sci. Monit., 2005, 11, RA359–367.
• 17. Halliwell B., Vitamin E and the treatment and prevention of diabetes: a case for a controlled clinical trial. Singapore Med. J., 2002, 43, 479–484.
• 18. Jain S., Gaiha M., Bhattacharjee J., Anuradha S., Effects of lowdose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress-a prospective preliminary study. J. Assoc. Physicians India, 2002, 50, 1028–1033.
• 19. Jarvinen R., Knekt P., Rissanen H., Reunanen A., Intake of fish and long-chain n-3 fatty acids and the risk of coronary heart mortality in men and women. Br. J. Nutr., 2006, 95, 824–829.
• 20. Johansen O., Seljeflot I., Høstmark A., Arnesen H., The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease arteriosclerosis. Throm. Vasc. Biol., 1999, 19, 1681–1686
• 21. Julius U., Fat modification in the diabetes diet. Exp. Clin. Endocrinol. Diabetes, 2003, 111, 60–65.
• 22. Kahn B.B., Pedersen O., Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity. Endocrinology, 1993, 132, 13–22.
• 23. Kesavulu M.M., Kameswararao B., Apparao Ch., Kumar E.G., Harinarayan C.V., Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes Metab,. 2002, 28, 20–26.
• 24. Kontush A., Hubner C., Finckh B., Kohlschutter A., Beisiegel U., How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach. Free Radic. Res., 1995, 24, 135–147.
• 25. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., Erdman J.W., Kris-Etherton P., Goldberg I.J., Kotchen T.A., Lichtenstein A.H., Mitch W.E., Mulllis R., Robinson K., Wylie-Rosett J., St. Joer S., Suttie J., Tribble D.L., Bazzarre T.L., AHA Dietary Guidelines: Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation, 2000, 102, 2284–2299.
• 26. Lovejoy J., The influence of dietary fat on insulin resistance. Curr. Diab. Rep., 2002, 2, 435–440.
• 27. Lyons T.J., Jenkins A.J., Lipoprotein glycation and its metabolic consequences. Curr. Opin. Lipidol., 1997, 8, 174–180.
• 28. Manuel-y-Keenoy B., Van Campenhout A., Aerts P., Vertommen J., Abrams P., Van Gaal L., Van Gils C., De Leeuw I., Time course of oxidative stress status in the postprandial and postabsorptive states in type 1 diabetes mellitus: relationship to glucose and lipid changes. J. Am. College Nutr., 2005, 24, 474–485.
• 29. Mori T.A., Dunstan D.W., Burke V., Croft K.D., Rivera J.H., Beilin L.J., Puddey I.B., Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism, 1999, 48, 1402–1408.
• 30. Mori T.A., Puddey I.B., Burke V., Croft K.D., Dunstan D.W., Rivera J.H., Beilin L.J., Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox. Rep., 2000, 5, 45–46.
• 31. Mori T.A., Woodman R.J., Burke V., Puddey I.B., Croft K.D., Beilin L.J., Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic. Biol. Med., 2003, 35, 772–781.
• 32. Morrow J., Roberts L., Their role as an index of oxidant stress status in human pulmonary disease. Am. J. Resp. Crit. Care Med., 2002, 166suppl., 25S-30S.
• 33. Moskaug J.O., Carlsen H., Myhrstad M., Blomhoff R., Molecular imaging of the biological effects of quercetin and quercetinrich foods. Mech. Ageing Dev., 2004, 125, 315–324.
• 34. NRC, National Research Council. Recommended dietary allowances. Washington, DC: National Academy Press, 1989.
• 35. Nettleton J.A., Katz R., n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J. Am. Diet. Assoc., 2005, 105, 428–440.
• 36. Ohia S.E., Opere C.A., Leday A.M., Pharmacological consequences of oxidative stress in ocular tissues. Mutat. Res., 2005, 579, 22–36.
• 37. Okouchi M., Okayama N., Aw T.Y., Hyperglycemia potentiates carbonyl stress-induced apoptosis in naive PC-12 cells: relationship to cellular redox and activator protease factor-1 expression. Curr. Neurovasc Res., 2005, 2, 375–386.
• 38. Pantsulaia T., Role of TGF-beta in pathogenesis of diabetic nephropathy. Georgian Med. News., 2006, 131, 13–28.
• 39. Pedersen H., Petersen M., Major-Pedersen A., Jensen T., Nielsen N.S., Lauridsen S.T., Marckmann P., Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes. Eur. J. Clin. Nutr., 2003, 57, 713–720.
• 40. Petersen K.F., Shulman G.I., Pathogenesis of skeletal muscle insulin resistance in Type 2 Diabetes Mellitus. Am. J. Cardiol., 2002, 90suppl., 11G–18G.
• 41. Rahman I., Adcock I.M., Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J., 2006, 28, 219–242.
• 42. Robertson R.P., Harmon J., Tran P.O., Poitout V., Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes, 2004, 53suppl., S119–S124.
• 43. Sanusi H., Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk. Acta Med. Indones., 2004, 36, 36–41.
• 44. Schulze M.B., Liu S., Rimm E.B., Manson J.E., Willett W.C., Hu, F.B., Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am. J. Clin. Nutr., 2004, 80, 348–356.
• 45. Sethi S., Ziouzenkova O., Ni H., Wagner D.D., Plutzky J., Mayadas T.N., Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPARα. Blood, 2002, 100, 1340–1346.
• 46. Sies H., Stahl W., Sevanian A., Nutritional, dietary and postprandial oxidative stress. J. Nutr., 2005, 135, 969–972.
• 47. Sima A.A., Pathological mechanisms involved in diabetic neuropathy: can we slow the process? Curr. Opin. Investig. Drugs., 2006, 7, 324–337.
• 48. Simpopoulos A., Laef A., Salem N., Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega- 3 fatty acids. ISSFAL Newsletter, 1999, 6, 14–15.
• 49. Tsai W.C., Li Y.H., Lin C.C., Chao T.H., Chen J.H., Effects of oxidative stress on endothelial function after a high-fat meal. Clin. Sci., 2004, 106, 315–319.
• 50. Turpeinen A.M., Alfthan G., Valsta L., Hietanen E., Salonen J.T., Schunk H., Nyyssonen K., Mutanen M., Plasma and lipoprotein lipid peroxidation in humans on sunflower and rapeseed oil diets. Lipids, 1995, 30, 485–492.
• 51. Ursini F., Sevanian A., Postprandial oxidative stress. Biol. Chem., 2002, 383, 599–605.
• 52. Vanschoonbeek K., de Maat M., Heemskerk J., Fish oil consumption and reduction of arterial disease. J. Nutr., 2003, 133, 657–660.
• 53. Vincent A.M., McLean L.L., Backus C., Feldman E.L. Short‑term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J., 2005, 19, 638–640.
• 54. Wander R.C., Du S.H., Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids. Am. J. Clin.Nutr., 2000, 72, 731–737.
• 55. Watson T.A., Callister R., Taylor R.D., Sibbritt D.W., MacDonald- Wicks L.K., Garg M.L., Antioxidant restriction and oxidative stress in short-duration exhaustive exercise. Med. Sci. Sports Exerc., 2005, 37, 63–71.
• 56. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27, 1047–1053.
• 57. Woodman R.J., Mori T.A., Burke V, Puddey I.B., Watts G.F., Beilin L.J., Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am. J. Clin. Nutr., 2002, 76, 1007–1015.
• 58. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D., Glutathione metabolism and its implications for health. J. Nutr., 2004, 134, 489–492.
• 59. Young I.S., McEneny J., Lipoprotein oxidation and atherosclerosis. Biochem. Soc. Trans., 2001, 2, 358–362.

Uwagi

PL

Rekord w opracowaniu